[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Cumhuriyet University Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":109},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,48,85],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100633832","patient-reported-outcomes-and-complications-after-structural-rhinoplasty-using-septal-extension-grafts-100633832",false,"NCT07531810","Patient-Reported Outcomes and Complications After Structural Rhinoplasty Using Septal Extension Grafts","Patient-Reported Outcomes and Complications Following Structural Rhinoplasty Using Septal Extension Grafts: A Prospective Cohort Study","SEG-PROM","Inclusion Criteria:\n\n* Age 18 years or older\n* Undergoing primary structural rhinoplasty with septal extension graft\n* Able to understand and complete patient-reported outcome questionnaires (PROMs)\n* Willing to participate and provide written informed consent\n\nExclusion Criteria:\n\n* History of previous nasal surgery (revision rhinoplasty)\n* Undergoing concomitant major craniofacial procedures\n* Missing preoperative PROM data\n* Unable to complete postoperative follow-up assessments","ALL","18 Years",{"count":20,"type":21},50,"ESTIMATED","6 Months","OBSERVATIONAL","Structural rhinoplasty with septal extension graft (SEG) is commonly used to achieve stable nasal tip support and predictable long-term outcomes. However, surgical success is not limited to structural stability alone and should also be evaluated from the patient's perspective.\n\nPatient-reported outcome measures (PROMs) have gained increasing importance in rhinoplasty, as they reflect patient satisfaction and perceived nasal function. Despite the widespread use of SEG, prospective studies evaluating PROMs together with postoperative clinical findings over time remain limited.\n\nThis prospective observational cohort study aims to evaluate longitudinal changes in patient-reported outcomes and postoperative findings in adult patients undergoing primary structural rhinoplasty with SEG-based nasal tip support. Validated PROM instruments will be applied preoperatively and during routine postoperative follow-up visits at approximately 1, 3, and 6 months.\n\nIn addition, postoperative complications and revision procedures will be recorded. The study aims to provide a more comprehensive understanding of patient-centered outcomes and their relationship with clinical findings in SEG-based rhinoplasty.",[26,27,28],"Nasal Deformity","Rhinoplasty","Nasal Obstruction",[30,31,32,33,34],"Structural rhinoplasty","Septal extension graft","Patient reported outcomes","SCHNOS","Rhinoplasty outcomes","RECRUITING","2026-06-17",{"date":38,"type":39},"2026-06-22","ACTUAL",{"date":41,"type":39},"2026-04-01",{"date":43,"type":21},"2027-06",{"name":45,"class":46},"Cumhuriyet University Hospital","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":56,"minAge":18,"maxAge":57,"enrollmentInfo":58,"targetDuration":4,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":70,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":47},"100641134","spsip-block-for-pain-control-after-breast-reduction-surgery-100641134","NCT07657949","SPSIP Block for Pain Control After Breast Reduction Surgery","Effect of Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block on Opioid Consumption After Reduction Mammaplasty: A Prospective Randomized Controlled Trial","SPSIP-RM","Inclusion Criteria:\n\n* Female participants aged 18 to 65 years\n* Scheduled for elective bilateral reduction mammaplasty\n* Planned surgery under general anesthesia\n* American Society of Anesthesiologists physical status class I to III\n* Planned postoperative clinical follow-up for the first 24 hours after surgery\n* Able to understand and report pain using the 0 to 10 Numeric Rating Scale\n* Able to provide written informed consent for study participation\n\nExclusion Criteria:\n\n* Known allergy or hypersensitivity to local anesthetic drugs\n* Contraindication to regional anesthesia or fascial plane block\n* Coagulopathy or clinically significant bleeding disorder\n* Use of anticoagulant or antiplatelet medication that prevents safe block application\n* Infection at the planned block injection site\n* Chronic opioid use, chronic pain syndrome, or regular analgesic use that may affect postoperative pain assessment\n* Revision breast surgery\n* Planned major additional surgical procedure other than reduction mammaplasty\n* Pregnancy or lactation\n* Unable to reliably report pain scores","FEMALE","65 Years",{"count":59,"type":21},80,"INTERVENTIONAL",[62],"NA","The goal of this clinical trial is to learn whether an ultrasound-guided serratus posterior superior intercostal plane block (SPSIP block) can lower the need for opioid pain medicine after breast reduction surgery.\n\nThe main question it aims to answer is: Does adding an SPSIP block to standard anesthesia and pain treatment lower opioid use during the first 24 hours after surgery? Researchers will compare participants who receive standard anesthesia and pain treatment with participants who receive standard anesthesia and pain treatment plus an SPSIP block.\n\nParticipants will:\n\n* Have planned bilateral breast reduction surgery under general anesthesia\n* Be randomly assigned to the SPSIP block group or the control group\n* Receive standard local anesthetic infiltration during surgery and standard pain treatment after surgery\n* Have their pain score and pain medicine use recorded during the first 24 hours after surgery\n* Be followed for safety and complications for 30 days after surgery",[65,66,67,68,69],"Postoperative Pain Breast Reduction","Mammaplasty","Analgesia","Nerve Block","Opioid Consumption, Postoperative",[71,72,73,74,75],"Serratus posterior superior intercostal plane block","Ultrasound-guided regional anesthesia","Reduction mammaplasty","Breast reduction surgery","Postoperative pain","NOT_YET_RECRUITING","2026-06-14",{"date":79,"type":39},"2026-06-18",{"date":81,"type":21},"2026-08-01",{"date":83,"type":21},"2027-08-31",{"name":45,"class":46},{"id":86,"slug":87,"hasResults":11,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":4,"eligibilityCriteria":91,"healthyVolunteers":11,"sex":56,"minAge":18,"maxAge":57,"enrollmentInfo":92,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":94,"conditions":95,"keywords":99,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":104,"startDateStruct":105,"completionDateStruct":106,"leadSponsor":108,"locationsCount":47},"100641052","autologous-free-dermal-graft-support-in-superior-pedicle-vertical-scar-reduction-mammaplasty-100641052","NCT07657962","Autologous Free Dermal Graft Support in Superior Pedicle Vertical Scar Reduction Mammaplasty","Effect of Autologous Free Dermal Graft Use on Lower Pole Stability in Superior Pedicle Vertical Scar Reduction Mammaplasty: A Prospective Comparative Cohort Study","Inclusion Criteria:\n\n* Female participants aged 18 to 65 years\n* Planned primary bilateral reduction mammaplasty\n* Planned use of the superior pedicle vertical scar technique\n* Willingness to attend at least 6 months of postoperative follow-up\n* Ability to provide written informed consent\n* Consent for standardized medical photography and clinical breast measurements\n\nExclusion Criteria:\n\n* Previous breast surgery\n* Oncoplastic breast reduction\n* Unilateral reduction mammaplasty\n* Use of a pedicle technique other than the superior pedicle\n* Use of a scar pattern other than the vertical scar pattern\n* Presence of a systemic condition expected to significantly impair wound healing\n* Active smoking within the last 6 weeks before surgery\n* Incomplete 6-month follow-up data for the primary outcome analysis",{"count":93,"type":21},70,"The goal of this observational study is to learn whether using an autologous free dermal graft during breast reduction surgery helps maintain lower breast pole shape over time in women undergoing primary bilateral reduction mammaplasty.\n\nThe main question it aims to answer is:\n\nDoes autologous free dermal graft support reduce lower pole lengthening between 1 month and 6 months after surgery?\n\nResearchers will compare two groups of participants. One group will undergo superior pedicle vertical scar reduction mammaplasty with autologous free dermal graft support as part of routine surgical care. The other group will undergo the same basic breast reduction technique without autologous free dermal graft support.\n\nParticipants will:\n\n* Have their planned breast reduction surgery as part of routine care\n* Attend postoperative follow-up visits at 1, 3, and 6 months\n* Have standard breast measurements and medical photographs taken during follow-up\n* Complete a breast satisfaction questionnaire at 6 months",[96,66,97,98],"Breast Ptosis","Lower Pole Elongation","Postoperative Breast Pseudoptosis",[73,100,101,102,103],"Superior pedicle","Autologous free dermal graft","Vertical scar reduction mammaplasty","Aesthetic outcome",{"date":79,"type":39},{"date":81,"type":21},{"date":107,"type":21},"2028-02-01",{"name":45,"class":46},""]